Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Kansen voor optimalisatie van cytotoxische behandeling van longkanker in het tijdperk van immunotherapie
dec 2025 | Longoncologie